Conversion from Sandimmune to Neoral in patients with stable renal allograft function: UHKL experience.
Goh
B L
BL
University Hospital, Kuala Lumpur, Malaysia.
Jalil
R
R
Koh
S N
SN
Chua
C T
CT
Tan
S Y
SY
D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004304:Dosage Forms; D005260:Female; D005500:Follow-Up Studies; D006785:Hospitals, University; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008296:Malaysia; D008297:Male; D013997:Time Factors; D014184:Transplantation, Homologous
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine